The present invention provides process of preparing solid oral pharmaceutical compositions comprising combination of metformin and sitagliptin or salts thereof. In particular, the present invention relates to process of preparing pharmaceutical composition comprising metformin and sitagliptin or salts thereof which is devoid of any surface active agents. The invention also includes method of use of such compositions for treating type II diabetes.